# 医療法 / Medical Care Act — 第三十六条 (Article 36) - Law: 医療法 (Medical Care Act), 昭和二十三年法律第二百五号 - English title "Medical Care Act": Ministry of Justice translation - Kind: Act — the distinction between 法律 (Act), 政令 (Cabinet Order), 省令 (Ministerial Order) and 条例 (local ordinance) decides who may issue it and what it may say. - Provision: 第三十六条 (Article 36) — address `art-36` - Text in force since: 2026-10-01 - URL (the page that opens at this provision): https://japanlaw.org/en/medical-care-act/art-36 - Permanent URL (e-Gov law ID, never renamed): https://japanlaw.org/l/323AC0000000205/art-36 - Every provision below carries its address and both URLs on the line under it. - Japanese text: e-Gov 法令検索, Digital Agency (デジタル庁). English: as marked on each line below. Only the Japanese as published by the government has legal effect; the text below is a copy of it. Every English rendering below is a translation and says which kind: the Ministry of Justice's translation, or this site's machine translation, whose model and date the Sources list names. They are never merged and never substituted for one another. --- ### 第三十六条 art-36 · https://japanlaw.org/en/medical-care-act/art-36 · https://japanlaw.org/l/323AC0000000205/art-36 **第一項** 厚生労働大臣は、特定医薬品（医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律第二条第十七項に規定する特定医薬品をいう。以下同じ。）について、その供給が不足し、又はその特定医薬品の需給の状況その他の状況から合理的に判断して、その供給が不足する蓋然性があると認められるため、適切な医療の提供が困難になることにより、国民の生命及び健康に影響を与えるおそれがあると認める場合は、製造販売業者（同法第十二条第一項の医薬品の製造販売業の許可を受けた者をいう。以下同じ。）、製造業者（同法第十三条第一項の医薬品の製造業の許可を受けた者をいう。以下同じ。）、卸売販売業者（同法第三十四条第一項の卸売販売業の許可を受けた者をいう。第三十八条の四において同じ。）その他の関係者に対し、当該特定医薬品又は代替薬（同法第十八条の五に規定する代替薬をいう。以下この条において同じ。）の増産、販売の調整その他の当該特定医薬品又は代替薬を必要とする医療提供施設に対する当該特定医薬品又は代替薬の提供を図るために必要な協力を求めることができる。 art-36/par-1 · https://japanlaw.org/en/medical-care-act/art-36/par-1 · https://japanlaw.org/l/323AC0000000205/art-36/par-1 When the Minister of Health, Labour and Welfare finds that the supply of a specified pharmaceutical (meaning a specified pharmaceutical prescribed in Article 2, paragraph (17) of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices; the same applies hereinafter) is in shortage, or is likely to be in shortage as reasonably judged from the state of supply and demand of the specified pharmaceutical and other circumstances, and that, as a result, the provision of appropriate medical care will become difficult, which may affect the lives and health of the people, the Minister may request marketing authorization holders (meaning persons who have obtained a license for the business of marketing pharmaceuticals under Article 12, paragraph (1) of that Act; the same applies hereinafter), manufacturers (meaning persons who have obtained a license for the business of manufacturing pharmaceuticals under Article 13, paragraph (1) of that Act; the same applies hereinafter), wholesale distributors (meaning persons who have obtained a license for the wholesale distribution business under Article 34, paragraph (1) of that Act; the same applies in Article 38-4) and other related parties to provide the cooperation necessary to ensure the provision of that specified pharmaceutical or an alternative pharmaceutical (meaning an alternative pharmaceutical prescribed in Article 18-5 of that Act; the same applies hereinafter in this Article) to medical institutions that need it, such as increasing the production of, and adjusting the sale of, that specified pharmaceutical or alternative pharmaceutical. machine translation, not official **第二項** 厚生労働大臣は、前項に規定する場合には、薬局開設者（医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律第一条の四に規定する薬局開設者をいう。）又は病院若しくは診療所の開設者その他の関係者に対し、調剤又は処方に関する配慮その他の当該特定医薬品又は代替薬を必要とする者に対する医療の提供を図るために必要な協力を求めることができる。 art-36/par-2 · https://japanlaw.org/en/medical-care-act/art-36/par-2 · https://japanlaw.org/l/323AC0000000205/art-36/par-2 In the case prescribed in the preceding paragraph, the Minister of Health, Labour and Welfare may request pharmacy establishers (meaning pharmacy establishers prescribed in Article 1-4 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices), the establishers of hospitals or clinics, and other related parties to provide the cooperation necessary to ensure the provision of medical care to persons who need that specified pharmaceutical or alternative pharmaceutical, such as consideration in dispensing or prescription. machine translation, not official --- ## Cites - art-36/par-1: 第三十八条の四 → 医療法 第三十八条の四 (Article 38-4), art-38-4 — https://japanlaw.org/en/medical-care-act/art-38-4 · https://japanlaw.org/l/323AC0000000205/art-38-4 - art-36/par-1: この条 → 医療法 第三十六条 (Article 36), art-36 — https://japanlaw.org/en/medical-care-act/art-36 · https://japanlaw.org/l/323AC0000000205/art-36 - art-36/par-2: 前項 → 医療法 第三十六条第一項 (Article 36, paragraph (1)), art-36/par-1 — https://japanlaw.org/en/medical-care-act/art-36/par-1 · https://japanlaw.org/l/323AC0000000205/art-36/par-1 ## Cited by 2 provisions cite this one. No official source publishes this direction. - 医療法 第三十六条第一項 — https://japanlaw.org/en/medical-care-act/art-36/par-1 · https://japanlaw.org/l/323AC0000000205/art-36/par-1 - 医療法 第三十六条第二項 — https://japanlaw.org/en/medical-care-act/art-36/par-2 · https://japanlaw.org/l/323AC0000000205/art-36/par-2 --- ## Sources - e-Gov 法令検索, Digital Agency (デジタル庁) — 医療法 — the text in force from 2026-10-01 (https://laws.e-gov.go.jp/law/323AC0000000205/20261001_507AC0000000087), retrieved 2026-10-19 - Japanese Law Translation Database System, Ministry of Justice (法務省) — Medical Care Act — Ministry of Justice translation (https://www.japaneselawtranslation.go.jp/en/laws/view/4006/tb), retrieved 2026-10-19 - claude-sonnet-5-5 — Machine translation, batch medical-care-act-20261019T151250-006, translated 2026-10-20 - This site's parser, version 210 — 医療法 — structure, counts, cross-references and defined terms, computed 2026-10-19